Indian Companies Ramping Up For Follow-On Biologics
This article was originally published in PharmAsia News
Executive Summary
Like Western companies, Indian drug makers are buying or forming alliances with biotechs to enrich their pipelines but with the added goal of ramping up to do what they currently do best: create generic versions of branded drugs